Disclosure of interest: Nothing to disclose E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.06 - IMAGING - Hyperacute P2080 - ESOC25-1542 CT PERFUSION IN CEREBELLAR STROKE: EVALUATION OF PERFUSION ABNORMALITIES Edoardo Ricci 1 , Giovanni Furlanis 1 , Milo Ajevi 2 , Emanuele Vincis 1 , Gabriele Prandin 1 , Laura Manicinelli 1 , Federica Palacino 1 , Quagliotto Magda 1 , Paola Caruso 1 , Marcello Naccarato 1 , Paolo Manganotti 1 1 Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste - ASUGI, University of Trieste, Trieste, Italy, 2 Department of Engineering and Architecture, University of Trieste, Trieste, Italy Background and Aims: Acute cerebellar ischemic stroke (ACIS) is characterized by often non-specific clinical signs such as vertigo or postural instability, with neuroimaging playing a pivotal role in assessment in the emergency setting
No evidence currently links BPC-157 to cancer, but long-term data in humans does not exist
ProHealth extends this architecture by adding both a postbiotic (directly delivered butyrate via ButyroGen) and a peptide (BPC-157) that pre-clinical animal research suggests may support the gastrointestinal environment - a mechanism the brand describes based on its own published references, not as an established human clinical outcome
Yes, you can
